PMCB
$0.01
Pharmacyte Biotech
$.00
10.83%
PMCB
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Friday
Jul 2
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when PMCB reports earnings?
Beat
Meet
Miss

Where is PMCB's stock price going from here?
Up
Flat
Down
Stock chart of PMCB
Analysts
Summary of analysts' recommendations for PMCB
Score
Grade
Pivots
Resistance
$0.02
$0.02
$0.01

$0.01

Support
$0.01
$0.01
$0.00
Tweet
Growth
Description
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.